BioCentury
ARTICLE | Clinical News

Provigil modafinil: Phase III data

August 8, 2005 7:00 AM UTC

In a 3-month, double-blind, U.S. Phase III trial in 209 patients, 200 mg Provigil reduced sleepiness and significantly improved performance vs. placebo. Patients taking Provigil had modest improvement...